Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dual HIV risk and vulnerabilities among women who use or inject drugs no single prevention strategy is the answer

Dual HIV risk and vulnerabilities among women who use or inject drugs no single prevention... REVIEW URRENT Dual HIV risk and vulnerabilities among women PINION who use or inject drugs: no single prevention strategy is the answer a b a Nabila El-Bassel , Wendee M. Wechsberg , and Stacey A. Shaw Purpose of review This article examines the dual HIV and sexually transmitted infection (STI) risk behaviors engaged in by women who use or inject drugs; the individual, social, and structural drivers of HIV and STI risk; prevention strategies; and the implications for multilevel, combined, sex-specific HIV prevention strategies. Recent findings Women who use or inject drugs, especially female sex workers, are at dual risk for HIV, the hepatitic C virus (HCV), and other STIs. In countries with HIV prevalence higher than 20% among injecting drug users (IDUs), female IDUs have slightly higher HIV prevalence than male IDUs. Women who use or inject drugs face multilevel drivers that increase their vulnerabilities to HIV, HCV, and STIs. Despite advances in behavioral HIV prevention strategies for this population, most prevention studies have not sufficiently targeted dyadic, social, and structural levels. Few recent advances in biomedical HIV prevention have focused on women who use drugs and their unique needs. Summary HIV prevention strategies and services need to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and Aids Wolters Kluwer Health

Dual HIV risk and vulnerabilities among women who use or inject drugs no single prevention strategy is the answer

Current Opinion in HIV and Aids , Volume 7 (4) – Jul 1, 2012

Loading next page...
 
/lp/wolters-kluwer-health/dual-hiv-risk-and-vulnerabilities-among-women-who-use-or-inject-drugs-hrjBeNIPPl

References (74)

Copyright
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0b013e3283536ab2
pmid
22498480
Publisher site
See Article on Publisher Site

Abstract

REVIEW URRENT Dual HIV risk and vulnerabilities among women PINION who use or inject drugs: no single prevention strategy is the answer a b a Nabila El-Bassel , Wendee M. Wechsberg , and Stacey A. Shaw Purpose of review This article examines the dual HIV and sexually transmitted infection (STI) risk behaviors engaged in by women who use or inject drugs; the individual, social, and structural drivers of HIV and STI risk; prevention strategies; and the implications for multilevel, combined, sex-specific HIV prevention strategies. Recent findings Women who use or inject drugs, especially female sex workers, are at dual risk for HIV, the hepatitic C virus (HCV), and other STIs. In countries with HIV prevalence higher than 20% among injecting drug users (IDUs), female IDUs have slightly higher HIV prevalence than male IDUs. Women who use or inject drugs face multilevel drivers that increase their vulnerabilities to HIV, HCV, and STIs. Despite advances in behavioral HIV prevention strategies for this population, most prevention studies have not sufficiently targeted dyadic, social, and structural levels. Few recent advances in biomedical HIV prevention have focused on women who use drugs and their unique needs. Summary HIV prevention strategies and services need to

Journal

Current Opinion in HIV and AidsWolters Kluwer Health

Published: Jul 1, 2012

There are no references for this article.